• Search History (Register)
  • MeSH Browser
  • [Clear]
    • English
    • Afrikaans
      Albanian
      Arabic
      Armenian
      Basque
      Bengali
      Bulgarian
      Catalan
      Cambodian
      Chinese (Mandarin)
      Chinese (Cantonese)
      Croatian
      Czech
      Danish
      Dutch
      English
      Estonian
      Fiji
      Finnish
      French
      Georgian
      German
      Greek
      Gujarati
      Hebrew
      Hindi
      Hungarian
      Icelandic
      Indonesian
      Irish
      Italian
      Japanese
      Javanese
      Korean
      Latin
      Latvian
      Lithuanian
      Macedonian
      Malay
      Malayalam
      Maltese
      Maori
      Marathi
      Mongolian
      Nepali
      Norwegian
      Persian
      Polish
      Portuguese
      Punjabi
      Quechua
      Romanian
      Russian
      Samoan
      Serbian
      Slovak
      Slovenian
      Spanish
      Swahili
      Swedish
      Tamil
      Tatar
      Telugu
      Thai
      Tibetan
      Tonga
      Turkish
      Ukrainian
      Urdu
      Uzbek
      Vietnamese
      Welsh
      Xhosa
      Apply
    • Adelaide Health Technology Assessment
      Agence d'évaluation des technologies et des modes d'intervention en santé
      Agencia de Evaluacion de Tecnologias Sanitarias
      Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS)
      Agencia de Qualitat i Avaluacio Sanitries de Catalunya
      Agency for Care Effectiveness (ACE)
      Agency for Health Technology Assessment and Tariff System
      Agency for Healthcare Research and Quality
      Agenzia Sanitaria e Sociale Regionale (Regional Agency for Health and Social Care)
      All Wales Medicines Strategy Group
      Andalusian Health Technology Assessment Area
      Australian Health Technology Advisory Committee
      Australian Safety and Efficacy Register of New Interventional Procedures-Surgical
      Austrian Institute for Health Technology Assessment
      Basque Office for Health Technology Assessment
      Belgian Health Care Knowledge Centre
      BlueCross BlueShield Association
      British Columbia Office of Health Technology Assessment
      Canadian Agency for Drugs and Technologies in Health
      Canadian Coordinating Office for Health Technology Assessment
      Canadian Task Force on Preventive Health Care
      Canary Health Service
      Cellule Innovation of the AP-HP
      Center for Drug Evaluation
      Center for Medical Technology Assessment
      Center for Outcomes Research and Economic Evaluation for Health
      Centre for Clinical Effectiveness
      Centre for Reviews and Dissemination
      Centre for Technology Assessment at the Swiss Science and Technology Council
      Centre Hospitalier de l'Universite de Montreal
      Centre intégré universitaire de santé et de services sociaux de la Capitale-Nationale
      Committee for New Health Technology Assessment
      Conseil d'Evaluation des Technologies de la Santé du Québec
      Coordenação-Geral de Fomento à Pesquisa e Avaliação de Tecnologias em Saúde, Departamento de Ciência e Tecnologia
      Danish Centre for Evaluation and Health Technology Assessment
      Danish Institute for Health Services Research
      ECRI Institute
      European Network for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Università Cattolica del Sacro Cuore
      German Agency for HTA at the German Institute for Medical Documentation and Information
      Gesundheit Osterreich GmbH
      Hannover Medical School, Medizinische Hochschule Hannover
      Haute Autorité de Santé
      HAYES, Inc.
      Health Council of the Netherlands Gezondheidsraad
      Health Information and Quality Authority (HIQA)
      Health Intervention and Technology Assessment Program
      Health Quality Ontario
      Health Sciences Institute in Aragon (IACS)
      Health Services Assessment Collaboration
      Health Services Utilization and Research Commission
      Health Technology Advisory Committee
      Health Technology and Policy Unit
      Health Technology Assessment Section, Ministry of Health Malaysia
      Health Technology Board for Scotland
      Health Technology Reference Group
      Health Technology Wales
      HTA Region Stockholm
      HTA South
      HTA Unit, University of Calgary
      Institut national d'excellence en sante et en services sociaux
      Institut universitaire de cardiologie et de pneumologie de Québec – Université Laval (IUCPQ-ULaval)
      Institute for Clinical and Economic Review
      Institute for Clinical Effectiveness and Health Policy
      Institute for Clinical Evaluative Sciences
      Institute for Clinical Systems Improvement
      Institute for Quality and Efficiency in Health Care (IQWiG)
      Institute of Applied Health Sciences
      Institute of Health Economics
      Institute of Health Economics
      Institute of Health Technology Assessment and Research (IETSI)
      Institute of Technology Assessment
      Israel Center for Technology Assessment in Health Care
      L'Agence Nationale d'Accreditation d'Evaluation en Santé
      Ludwig Boltzmann Institute for Health Technology Assessment
      Malaysian Health Technology Assessment
      Malaysian Health Technology Assessment Unit
      Medical Advisory Secretariat
      Medical Services Advisory Committee
      Monash Business School, Monash University (MBS)
      National Authority for Assessment and Accreditation in Healthcare (INEAS)
      National Committee for Technology Incorporation (CONITEC)
      National Evidence-based healthcare Collaborating Agency
      National Institute for Clinical Excellence
      National Institute for Health and Care Excellence
      New Zealand Health Technology Assessment
      New Zealand National Health Committee
      NIHR Health and Social Care Delivery Program
      NIHR Health Services and Delivery Research programme
      NIHR Health Technology Assessment programme
      NIHR Horizon Scanning Centre
      NIHR Public Health Research programme
      Norwegian Institute of Public Health
      Norwegian Institute of Public Health
      Norwegian Medical Products Agency
      Ontario Health
      Penn Medicine Center for Evidence-based Practice
      Quality Improvement Scotland
      Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)
      Scottish Health Purchasing Information Centre
      Scottish Health Technologies Group
      Scottish Medicines Consortium (SMC)
      State Health Care Accreditation Agency under the Ministry of Health of the Republic of Lithuania
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swiss Federal Office of Public Health (FOPH)
      Technology Assessment at SickKids
      Technology Assessment Unit of the McGill University Health Centre (MUHC)
      The Danish Health Technology Council
      The Federal Joint Committee
      The HTA Center of the Stockholm County Council/Gotland
      The Italian National Agency for Regional Health Services (Agenas)
      The National Health Care Institute (ZIN, Zorginstituut Nederland)
      The National Health Care Institute (Zorginstituut Nederland)
      The Netherlands Organisation for Health Research and Development
      The Regional Health Technology Assessment Centre
      TNO
      U. S. Congress. Office of Technology Assessment
      Unidad de Evaluacion de Tecnologias Sanitarias
      Unidad de Tecnologias de Salud
      Unit of Health Economics and Technology Assessment in Health Care
      University HealthSystem Consortium
      University of York
      VA Technology Assessment Program
      Washington Singer Press
      Washington State Department of Labor and Industries (WSDLI)
      Wessex Institute for Health Research and Development
      West Midlands Health Technology Assessment Collaboration
      WorkSafeBC
      Apply
    • Afghanistan
      Albania
      Algeria
      Andorra
      Antigua and Barbuda
      Argentina
      Armenia
      Australia
      Austria
      Azerbaijan
      Bahamas
      Bahrain
      Bangladesh
      Barbados
      Belarus
      Belgium
      Belize
      Benin
      Bhutan
      Bolivia
      Bosnia and Herzegovina
      Botswana
      Brazil
      Brunei
      Bulgaria
      Burkina Faso
      Burundi
      Cambodia
      Cameroon
      Canada
      Cape Verde
      Central African Republic
      Chad
      Chile
      China
      Colombia
      Comoros
      Congo
      Costa Rica
      Cote dIvoire
      Croatia
      Cuba
      Cyprus
      Czech Republic
      Denmark
      Djibouti
      Dominica
      Dominican Republic
      East Timor
      Ecuador
      Egypt
      El Salvador
      Equatorial Guinea
      Eritrea
      Estonia
      Ethiopia
      Fiji
      Finland
      France
      Gabon
      Gambia
      Georgia
      Germany
      Ghana
      Greece
      Grenada
      Guatemala
      Guinea
      Guinea-Bissau
      Guyana
      Haiti
      Honduras
      Hong Kong
      Hungary
      Iceland
      India
      Indonesia
      Iran
      Iraq
      Ireland
      Israel
      Italy
      Jamaica
      Japan
      Jordan
      Kazakhstan
      Kenya
      Kiribati
      North Korea
      South Korea
      Kuwait
      Kyrgyzstan
      Laos
      Latvia
      Lebanon
      Lesotho
      Liberia
      Libya
      Liechtenstein
      Lithuania
      Luxembourg
      Macedonia
      Madagascar
      Malawi
      Malaysia
      Maldives
      Mali
      Malta
      Marshall Islands
      Mauritania
      Mauritius
      Mexico
      Micronesia
      Moldova
      Monaco
      Mongolia
      Montenegro
      Morocco
      Mozambique
      Myanmar
      Namibia
      Nauru
      Nepal
      Netherlands
      New Zealand
      Nicaragua
      Niger
      Nigeria
      Norway
      Oman
      Pakistan
      Palau
      Panama
      Papua New Guinea
      Paraguay
      Peru
      Philippines
      Poland
      Portugal
      Puerto Rico
      Qatar
      Romania
      Russia
      Rwanda
      Saint Kitts and Nevis
      Saint Lucia
      Saint Vincent and the Grenadines
      Samoa
      San Marino
      Sao Tome and Principe
      Saudi Arabia
      Senegal
      Serbia and Montenegro
      Seychelles
      Sierra Leone
      Singapore
      Slovakia
      Slovenia
      Solomon Islands
      Somalia
      South Africa
      Spain
      Sri Lanka
      Sudan
      Suriname
      Swaziland
      Sweden
      Switzerland
      Syria
      Taiwan
      Tajikistan
      Tanzania
      Thailand
      Togo
      Tonga
      Trinidad and Tobago
      Tunisia
      Turkey
      Turkmenistan
      Tuvalu
      Uganda
      Ukraine
      United Arab Emirates
      United Kingdom
      United States
      Uruguay
      Uzbekistan
      Vanuatu
      Vatican City
      Venezuela
      Vietnam
      Yemen
      Zambia
      Zimbabwe
      Apply

Welcome to the international HTA database

CSV RIS
Showing [16394 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2009     NIHR Health Technology Assessment programme Gemcitabine for the treatment of metastatic breast cancer
2009     NIHR Health Technology Assessment programme A multicentre randomised controlled trial of the use of continuous positive airway pressure and non-invasive positive pressure ventilation in the early treatment of patients presenting to the emergency department with severe acute cardiogenic pulmonary oedema: the 3CPO Trial
2009     Penn Medicine Center for Evidence-based Practice (CEP) Post operative use of COX-2 inhibitors in bone surgery
2009     NIHR Horizon Scanning Centre (NIHR HSC) Cediranib (Recentin) for recurrent glioblastoma multiforme - second or third line
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Fecal immunochemical tests for colorectal cancer screening of average risk individuals: a systematic review of accuracy and compliance
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Point-of-care HIV testing: a review of the clinical and cost-effectiveness and diagnostic accuracy
2009     NIHR Health Technology Assessment programme Varenicline in the management of smoking cessation: a single technology appraisal
2009     NIHR Health Technology Assessment programme Randomised controlled trial of the use of the three dressing preparations in the management of chronic ulceration of the foot in diabetes
2009     Penn Medicine Center for Evidence-based Practice (CEP) High frequency jet ventilation in cardiac ablation procedures
2009     NIHR Horizon Scanning Centre (NIHR HSC) Cediranib (Recentin) with XELOX or FOLFOX for advanced metastatic colorectal cancer - first line
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Computed tomography: a review of the risk of cancer associated with radiation exposure
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Acupuncture for managing chronic shoulder and lower back pain: a review of optimal frequency
2009     NIHR Health Technology Assessment programme Alteplase for the treatment of acute ischaemic stroke: a single technology appraisal
2009     NIHR Health Technology Assessment programme Randomised controlled trial to determine the clinical and cost-effectiveness of selective serotonin reuptake inhibitors plus supportive care, versus supportive care alone, for mild to moderate depression with somatic symptoms in primary care. The THREAD (THREshold for AntiDepressant response) study
2009     NIHR Health Technology Assessment programme Methods to identify postnatal depression in primary care: an integrated evidence synthesis and value of information analysis
2009     NIHR Health Technology Assessment programme Deferasirox for the treatment of iron overload associated with regular blood transfusions (transfusional hemosiderosis) in patients suffering with chronic anaemia: a systematic review and economic evaluation
2009     Penn Medicine Center for Evidence-based Practice (CEP) Observation units
2009     NIHR Horizon Scanning Centre (NIHR HSC) Ataluren for nonsense mutation dystrophinopathy
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) TomoTherapy, Gamma Knife, and CyberKnife therapies for patients with tumors of the lung, central nervous system, or intra-abdomen: a systematic review of clinical effectiveness and cost effectiveness
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Subcutaneous administration of proton pump inhibitors in palliative care patients: a review of clinical effectiveness and guidelines
2009     NIHR Health Technology Assessment programme Rituximab for the treatment of rheumatoid arthritis
2009     Agenzia sanitaria e sociale regionale, Regione Emilia-Romagna (ASSR) Implantable device for the treatment of drug-resistant hypertension
2009     Penn Medicine Center for Evidence-based Practice (CEP) Mechanical prophylaxis for venous thromboembolism after ambulatory surgery
2009     NIHR Horizon Scanning Centre (NIHR HSC) Albinterferon alfa-2b (Joulferon) for hepatitis C with compensated liver disease
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Subcutaneous lidocaine in community care: a review of the guidelines and patient safety
2009     NIHR Health Technology Assessment programme Omalizumab for the treatment of severe persistent allergic asthma
2009     Penn Medicine Center for Evidence-based Practice (CEP) Management of diabetic ketoacidosis in wards/intermediate care units
2009     NIHR Horizon Scanning Centre (NIHR HSC) Aflibercept (VEGF-Trap) for locally advanced or metastatic non-small cell lung cancer - second line
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Managing crohn's disease in adults: a summary of the guidelines
2009     NIHR Health Technology Assessment programme Adalimumab for the treatment of psoriasis
2009     NIHR Health Technology Assessment programme The effects of biofeedback for the treatment of essential hypertension: a systematic review
2009     Penn Medicine Center for Evidence-based Practice (CEP) Isosmolar iodixanol versus low-osmolar contrast agents for imaging
2009     NIHR Horizon Scanning Centre (NIHR HSC) AEGR-733 (Lomitapide) for hypercholesterolaemia
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Dabigatran or Rivaroxaban versus other anticoagulants for thromboprophylaxis after major orthopedic surgery: systematic review of comparative clinical-effectiveness and safety
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Gliclazide MR versus glyburide for management of type 2 diabetes: a review of the clinical effectiveness and safety
2009     NIHR Health Technology Assessment programme Romiplostim for the treatment of chronic immune or idiopathic thrombocytopenic purpura: a single technology appraisal
2009     NIHR Health Technology Assessment programme The effect of different treatment durations of clopidogrel in patients with non-ST-segment elevation acute coronary syndromes: a systematic review and value of information analysis
2009     HAYES, Inc. Phototherapy for acne vulgaris
2009     NIHR Horizon Scanning Centre (NIHR HSC) Aflibercept (VEGF-Trap) for metastatic colorectal cancer - second line
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Sharp and round optic edges of intraocular lenses: a review of the clinical and cost-effectiveness
2009     NIHR Health Technology Assessment programme Sunitinib for the treatment of gastrointestinal stromal tumours: a critique of the submission from Pfizer
2009     HAYES, Inc. Positron emission tomography (PET) for diagnosing and staging lung cancer
2009     NIHR Horizon Scanning Centre (NIHR HSC) Cabazitaxel (XRP-6258) for hormone refractory, metastatic prostate cancer - second line after docetaxel
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Dialectical Behavior Therapy in adolescents for suicide prevention: Systematic review of clinical-effectiveness
2009     Blue Cross Blue Shield Association (BCBS) Special report: vaccines for the treatment of prostate cancer
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Hypertonic saline nebules for patients with cystic fibrosis and bronchioectasis: a review of the clinical and cost-effectiveness
2009     NIHR Health Technology Assessment programme Trastuzumab for the treatment of primary breast cancer in HER2-positive women: a single technology appraisal
2009     NIHR Health Technology Assessment programme VenUS II: a randomised controlled trial of larval therapy in the management of leg ulcers
2009     NIHR Health Technology Assessment programme Use of classical and novel biomarkers as prognostic risk factors for prostate cancer: a systematic review
2009     HAYES, Inc. Positron emission tomography (PET) for treatment planning of lung cancer
2009     NIHR Horizon Scanning Centre (NIHR HSC) Neurology monitoring (Entropy) for depth of anaesthesia
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Portable monitoring devices for diagnosis of obstructive sleep apnea at home: review of accuracy, cost effectiveness, guidelines, and coverage in Canada
2009     Blue Cross Blue Shield Association (BCBS) Percutaneous vertebroplasty or kyphoplasty for vertebral fractures caused by osteoporosis
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Naltrexone for the treatment of alcohol dependence: a review of the clinical and cost-effectiveness
2009     NIHR Health Technology Assessment programme Docetaxel for the adjuvant treatment of early breast cancer
2009     NIHR Health Technology Assessment programme Amantadine, oseltamivir and zanamivir for the prophylaxis of influenza (including a review of existing guidance no. 67): a systematic review and economic evaluation
2009     NIHR Horizon Scanning Centre (NIHR HSC) Eplivanserin for chronic insomnia characterised by difficulties with sleep maintenance
2009     Health Intervention and Technology Assessment Program (HITAP) The Thai population based preference scores for EQ5D health states
2009     Blue Cross Blue Shield Association (BCBS) Cardiac resynchronization therapy for mild congestive heart failure
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Oral endotracheal tube placement in neonates, pediatric, and adult patients: a review of the guidelines
2009     NIHR Horizon Scanning Centre (NIHR HSC) Eribulin for locally advanced or metastatic breast cancer - third line; monotherapy
2009     Health Intervention and Technology Assessment Program (HITAP) Assessing the implication of Thailand's government use licenses issued in 2006-2008
2009     Blue Cross Blue Shield Association (BCBS) Accelerated radiotherapy after breast-conserving surgery for early stage breast cancer
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Treatment of hydromyelia in adults: a review of clinical effectiveness and guidelines
2009     NIHR Health Technology Assessment programme Continuous positive airways pressure (CPAP) for the treatment of obstructive sleep apnoea/hypopnoea syndrome (OSAHS)
2009     NIHR Health Technology Assessment programme Spinal cord stimulation for chronic pain of neuropathic or ischaemic origin: systematic review and economic evaluation
2009     NIHR Horizon Scanning Centre (NIHR HSC) Indacaterol (Onbrez Breezhaler) for chronic obstructive pulmonary disease
2009     Health Intervention and Technology Assessment Program (HITAP) The potential of provider-initiated voluntary HIV counseling and testing at health care settings in Thailand
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Reassessment of health technologies: obsolescence and waste
2009     Blue Cross Blue Shield Association (BCBS) Special report: laboratory testing to allow area under the curve (AUC) - targeted 5-Fluorouracil dosing for patients administered chemotherapy for cancer
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Surgical dental interventions for use in children and adults: a review of the comparative clinical and cost-effectiveness
2009     NIHR Health Technology Assessment programme The effectiveness and cost-effectiveness of cochlear implants for severe to profound deafness in children and adults: a systematic review and economic model
2009     NIHR Health Technology Assessment programme Endovascular stents for abdominal aortic aneurysms
2009     NIHR Horizon Scanning Centre (NIHR HSC) Ofatumumab for follicular non-Hodgkin's lymphoma - refractory
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Development and testing of search filters to identify economic evaluations in MEDLINE and EMBASE
2009     Blue Cross Blue Shield Association (BCBS) Genetic testing for predisposition to inherited hypertrophic cardiomyopathy
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Cardiac Magnetic Resonance Imaging (MRI) for patients with coronary artery disease: a review of diagnostic accuracy
2009     Norwegian Knowledge Centre for the Health Services (NOKC) Rehabilitation of breast cancer patients
2009     NIHR Health Technology Assessment programme Routine antenatal anti-D prophylaxis for RhD-negative women: a systematic review and economic evaluation
2009     NIHR Health Technology Assessment programme The effectiveness and cost-effectiveness of machine perfusion systems and cold static storage of donated kidneys
2009     NIHR Horizon Scanning Centre (NIHR HSC) Patupilone (EPO906) for recurrent epithelial ovarian cancer - refractory and/or resistant
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Long-Acting Beta2-Agonist and Inhaled Corticosteroid Combination Therapy for Adult Persistent Asthma: Systematic Review of Clinical Outcomes and Economic Evaluation
2009     Blue Cross Blue Shield Association (BCBS) Angioplasty and stenting of the cervical carotid artery with embolic protection of the cerebral circulation
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Multi-slice computed tomography coronary angiography for coronary artery disease: a review of the clinical effectiveness and guidelines
2009     NIHR Health Technology Assessment programme Clinical and cost effectiveness of epoprostenol, iloprost, bosentan, sitaxentan, and sildenafil for the treatment of pulmonary arterial hypertension within their licensed indications: a systematic review and economic evaluation
2009     NIHR Health Technology Assessment programme Infliximab for the treatment of adults with psoriasis
2009     NIHR Health Technology Assessment programme Early high-dose lipid-lowering therapy to avoid cardiac events: a systematic review and economic evaluation
2009     NIHR Horizon Scanning Centre (NIHR HSC) Pirfenidone for idiopathic pulmonary fibrosis
2009     Blue Cross Blue Shield Association (BCBS) Pharmacogenetic testing to predict serious toxicity from 5-Fluorouracil (5-FU) for patients administered 5-FU-based chemotherapy for cancer
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Follow-up to 'The role of pharmacologic management in neovascular age- related macular degeneration: clinical and cost-effectiveness'
2009     NIHR Health Technology Assessment programme Zanamivir, oseltamivir and amantadine for the treatment of influenza (an update review of existing guidance)
2009     NIHR Horizon Scanning Centre (NIHR HSC) Quetiapine (Seroquel XL) for major depressive disorder
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Indirect calorimetry to measure energy requirements: a review of the guidelines and clinical effectiveness
2009     NIHR Health Technology Assessment programme Lapatinib for the treatment of HER2-overexpressing breast cancer
2009     NIHR Health Technology Assessment programme Febuxostat for the treatment of hyperuricaemia in people with gout: a single technology appraisal
2009     NIHR Horizon Scanning Centre (NIHR HSC) Ranibizumab (Lucentis) for macular oedema secondary to central or branch retinal vein occlusion
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) C-reactive protein levels for cardiovascular disease screening: a review of accuracy, use, and guidelines
2009     NIHR Health Technology Assessment programme Rituximab for the treatment of relapsed or refractory stage III or IV follicular non-Hodgkin's lymphoma
2009     NIHR Health Technology Assessment programme Enhanced external counterpulsation for stable angina or heart failure: a systematic review and economic evaluation
2009     NIHR Horizon Scanning Centre (NIHR HSC) Ranibizumab (Lucentis) for diabetic macular oedema